Merck is launching Crixivan through a mail-order pharmacy

Community pharmacists are crying foul because Merck is launching Crixivan through a mail-order pharmacy...until they reach full production in about six months.

The idea is to limit the number of patients who START Crixivan...until Merck can ensure adequate supplies for refills. Sporadic treatment could hasten the development of resistance.

Crixivan costs about 30% less than Norvir or Invirase. For info on enrolling patients, call 800/927-8888.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote